Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Robins Harlan S sold 386,240 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Jul 2, 2026 · Filed Jul 7, 2026

On Jul 2, 2026, Robins Harlan S (Chief Scientific Officer) sold 386,240 Adaptive Biotechnologies Corporation shares at an average US$22.01 for US$8.5M under a trading plan, leaving 1,019,658 shares. Filed Jul 7, 2026 (Form 4).

Sold
386,240 shares
Price
US$22.01 average (US$21.74 to US$22.45)
Value
US$8.5M
Holding after
1,019,658 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 2, 2026Common StockSale239,351US$21.741,166,547Direct
Jul 2, 2026Common StockSale146,889US$22.451,019,658Direct

Source

View original at SEC

Related